<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>impact of aging on oyster susceptibility &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/impact-of-aging-on-oyster-susceptibility/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Fri, 04 Sep 2026 03:46:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>impact of aging on oyster susceptibility &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Multiomics approach reverses age-related disease susceptibility in oysters</title>
		<link>https://scienmag.com/multiomics-approach-reverses-age-related-disease-susceptibility-in-oysters/</link>
		
		<dc:creator><![CDATA[Beatrice Stafford]]></dc:creator>
		<pubDate>Fri, 04 Sep 2026 03:46:21 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[age-related disease resistance in oysters]]></category>
		<category><![CDATA[biological paradox of aging in marine invertebrates]]></category>
		<category><![CDATA[epigenomics and metabolomics in oyster health]]></category>
		<category><![CDATA[epigenomics and transcriptomics in disease resistance]]></category>
		<category><![CDATA[genomics and disease susceptibility in mollusks]]></category>
		<category><![CDATA[immune system adaptation in aging oysters]]></category>
		<category><![CDATA[impact of aging on oyster susceptibility]]></category>
		<category><![CDATA[implications for sustainable oyster farming and disease management]]></category>
		<category><![CDATA[integrative multiomics in aquaculture research]]></category>
		<category><![CDATA[integrative multiomics studies in marine biology]]></category>
		<category><![CDATA[lifespan and immune function in oysters]]></category>
		<category><![CDATA[metabolomics in oyster immune response]]></category>
		<category><![CDATA[molecular basis of age-related resilience in oysters]]></category>
		<category><![CDATA[molecular mechanisms of oyster immunity]]></category>
		<category><![CDATA[molecular mechanisms of oyster survival against POMS]]></category>
		<category><![CDATA[multiomics analysis oyster disease resistance aging]]></category>
		<category><![CDATA[multiomics approaches in marine biology]]></category>
		<category><![CDATA[oyster aging and pathogen interaction]]></category>
		<category><![CDATA[oyster genome and pathogen response]]></category>
		<category><![CDATA[paradox of aging and resistance in marine organisms]]></category>
		<category><![CDATA[POMS oyster mortality and pathogen interaction]]></category>
		<category><![CDATA[reversing age-related disease susceptibility in marine invertebrates]]></category>
		<category><![CDATA[role of transcriptomics in oyster disease resistance]]></category>
		<guid isPermaLink="false">https://scienmag.com/multiomics-approach-reverses-age-related-disease-susceptibility-in-oysters/</guid>

					<description><![CDATA[In the world of infectious disease, aging is almost universally a liability. As animals grow older, their immune systems typically falter, their cellular repair mechanisms decline, and their susceptibility to pathogens climbs. Humans, mice, fish, and insects all obey this grim rule. But the Pacific oyster, Magallana gigas, has quietly been breaking it. A new [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In the world of infectious disease, aging is almost universally a liability. As animals grow older, their immune systems typically falter, their cellular repair mechanisms decline, and their susceptibility to pathogens climbs. Humans, mice, fish, and insects all obey this grim rule. But the Pacific oyster, <em>Magallana gigas</em>, has quietly been breaking it. A new study published in BMC Biology reveals that as these oysters age, they become dramatically more resistant to Pacific oyster mortality syndrome (POMS), a devastating panzootic disease caused by the ostreid herpesvirus type 1 microvariant (OsHV-1 μVar) that has devastated oyster farming operations across the globe. The research team, led by Alejandro Valdivieso, Guillaume Mitta, and Jeremie Vidal-Dupiol of the University of Montpellier and collaborators at Ifremer and the University of Perpignan Via Domitia, went beyond merely confirming this paradox. Using an ambitious integrative multiomics approach—combining epigenomics, transcriptomics, and metabolomics—they uncovered the molecular machinery behind this reversal of fortune, and in doing so, they may have opened a new chapter in our understanding of how life stages, genomes, and pathogens interact.</p>
<p>The findings are striking because they invert one of biology&#8217;s most dependable patterns. POMS kills juvenile oysters in staggering numbers, wiping out entire year classes of cultivated animals within weeks of warm-water conditions triggering viral replication. Farmers in France, and indeed around the world, have watched their juvenile stock collapse with a regularity that has made the disease one of the most economically destructive forces in modern aquaculture. Yet the oysters that survive into adulthood face the very same virus with remarkable composure. To understand why, the researchers designed an experiment that spanned three consecutive years, tracking four biparental families of oysters raised under controlled conditions at Ifremer&#8217;s experimental facilities in Argenton and Bouin. The oysters were challenged with the virus at three distinct ages: 4 months, 16 months, and 28 months. The results confirmed the paradox with clinical clarity—older oysters consistently survived POMS at rates that their juvenile counterparts could not approach.</p>
<p>With the survival pattern established, the team narrowed their focus to the two families that displayed the most pronounced age-related gains in survival and subjected them to an exhaustive molecular interrogation. The epigenomic arm of the study employed enzymatic methyl-sequencing (EM-seq) to map DNA methylation across more than two million cytosine–phosphate–guanine (CpG) sites per family, allowing the researchers to track how chemical marks on the genome shift as the animals age. The transcriptomic arm quantified the expression of 25,476 genes across all age groups. The metabolomic arm measured the abundance of 74 primary metabolites, capturing the biochemical state of the animals at each life stage. The integration of these three datasets—each informative on its own, but transformative in combination—revealed a coordinated, system-wide reprogramming that accompanies the oysters&#8217; transition from vulnerable juveniles to resilient adults.</p>
<p>At the heart of this reprogramming lies the epigenetic remodeling of immune regulators. The researchers observed that as oysters aged, the DNA methylation patterns governing genes such as toll-like receptors (TLRs) and myeloid differentiation primary response 88 (MyD88)—both critical sentinels of the innate immune system—shifted in ways that aligned with transcriptional changes in the nuclear factor-kappa B (NF-κB) pathway and the ubiquitin signaling cascade. NF-κB is a central hub of immune activation across the animal kingdom, orchestrating the cellular response to viral and bacterial threats. The aged oysters were not simply cranking up this pathway indiscriminately. Instead, they had tuned it into a state of enhanced antiviral activity, a configuration that appears to be calibrated for precisely the kind of viral challenge that POMS represents. In juvenile oysters, the same regulators are methylated and expressed in ways that leave the antiviral arsenal comparatively muted.</p>
<p>Perhaps the most compelling discovery concerns the mechanistic target of rapamycin (mTOR), a signaling molecule that serves as the cell&#8217;s master regulator of growth and metabolism. The study found that mTOR signaling is progressively repressed as oysters age. This single shift cascades into profound downstream consequences. When mTOR activity declines, cells redirect their resources away from rapid growth and protein synthesis and toward autophagy, the cellular self-cleaning process that breaks down damaged components and, critically, can degrade viral particles that have infiltrated the cell. In effect, the aging oyster is trading youthful exuberance for a form of cellular housekeeping that doubles as an antiviral weapon. The mTOR pathway has been extensively studied in the context of aging research in mammals, where its pharmacological inhibition by rapamycin extends lifespan in laboratory mice. The oyster study suggests that in at least one organism, natural aging accomplishes through developmental reprogramming what mammalian biologists have tried to achieve with drugs—a metabolic shift toward maintenance and away from growth.</p>
<p>The metabolic dimension of this transformation is equally revealing. The metabolomic data showed that older oysters exhibit reduced activity of the tricarboxylic acid (TCA) cycle, the central engine of cellular energy production. Alongside this, the researchers documented altered nitrogen metabolism and shifts in glutathione dynamics, including changes in the balance between reduced glutathione (GSH) and oxidized glutathione (GSSG), a key indicator of cellular oxidative stress. Glutathione is the cell&#8217;s principal antioxidant, and its careful management is essential for survival in environments where reactive oxygen species (ROS) can accumulate rapidly. Taken together, these metabolic signatures paint a picture of a stress-tolerant, energy-conserving phenotype—a cellular economy that prioritizes endurance over expansion. Juvenile oysters, by contrast, are metabolically configured for rapid growth, channeling energy into shell building and somatic development at the expense of viral defense.</p>
<p>What makes this study particularly significant is the mechanistic coherence it achieves across biological scales. The epigenetic changes are not random age-related drift; they are functionally connected to the transcriptional rewiring of specific immune pathways, and those transcriptional changes are in turn mirrored by the metabolic state of the animal. DNA methylation at immune gene loci correlates with altered expression of those same genes, which correlates with enhanced antiviral signaling, which correlates with reduced viral replication and improved survival. This is not correlation dressed up as causation; it is a multi-layered argument for a genuine, age-driven reprogramming of the host&#8217;s relationship with its pathogen.</p>
<p>The implications extend well beyond oyster biology. If aging can be reconfigured to produce disease resistance rather than susceptibility, then the assumption that old age and vulnerability are inseparable may be more context-dependent than previously thought. The oyster is an invertebrate lacking adaptive immunity, relying entirely on innate immune mechanisms. That an organism with such a comparatively simple immune architecture can achieve sophisticated, age-calibrated antiviral preparedness through epigenetic and metabolic reprogramming suggests that these mechanisms are deeply conserved and may be manipulable in other species, including those of agricultural and even medical importance. For aquaculture specifically, the findings hint at possible interventions: if the epigenetic state of juvenile oysters could be nudged toward the adult configuration, or if selective breeding could identify families that achieve this reprogramming earlier, the industry might gain a tool against a disease that has cost billions of dollars.</p>
<p>The research also carries implications for the study of aging itself. Much of gerontology is built around the premise that aging is a process of accumulated damage and declining function. The oyster data complicate this narrative. In these animals, aging is not merely a descent into dysfunction; it is a purposeful developmental transition, complete with its own regulatory logic. The coordinated changes in methylation, gene expression, and metabolism suggest that the aging process in <em>M. gigas</em> is programmed, not accidental. This raises the question of whether other organisms, including humans, harbor latent age-related programs that, under the right conditions, could enhance rather than diminish disease resistance.</p>
<p>For now, the oyster stands as a quiet rebuke to the assumption that vulnerability must accompany age. In the tide pools and farm rows of the world&#8217;s coastlines, an animal with no antibodies and no adaptive immune memory has solved a problem that medicine has struggled with for decades, simply by reorganizing its chemistry as it grows older. The herpesvirus that devastates its young meets an adult whose epigenome has been rewritten, whose immune pathways have been retuned, and whose metabolism has been rebuilt for war. The researchers hope that understanding this transformation will one day allow scientists to reproduce it at will—not just in oysters, but in any organism where growth and defense have been locked in an unfavorable trade-off. The juvenile oyster, in its rush to grow, leaves the door open to its worst enemy. The adult oyster, having grown, quietly closes it.</p>
<hr />
<div class="scienmag-article-metadata"><strong>Subject of Research:</strong> Age-related multiomics reprogramming (epigenomic, transcriptomic, and metabolomic) that reverses disease susceptibility in the Pacific oyster <em>Magallana gigas</em> exposed to Pacific oyster mortality syndrome (POMS).</p>
<p><strong>Article Title:</strong> Multiomics reprogramming reverses disease susceptibility in <em>Magallana gigas</em> during aging</p>
<p><strong>Article References:</strong> Valdivieso, A., Duperret, L., Petton, B., Courtay, G., Romatif, O., Pouzadoux, J., Henry, S., Turtoi, A., Toulza, E., Lagorce, A., Degremont, L., Morga, B., Vignal, E., Cosseau, C., Pernet, F., Mitta, G., &amp; Vidal-Dupiol, J. (2026). Multiomics reprogramming reverses disease susceptibility in Magallana gigas during aging. <em>BMC Biology</em>. <a href="https://doi.org/10.1186/s12915-026-02722-4" target="_blank" rel="noopener noreferrer">https://doi.org/10.1186/s12915-026-02722-4</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1186/s12915-026-02722-4" target="_blank" rel="noopener noreferrer">10.1186/s12915-026-02722-4</a></p>
<p><strong>Keywords:</strong> Aging, Pacific oyster mortality syndrome, POMS, OsHV-1 μVar, epigenomics, DNA methylation, transcriptomics, metabolomics, NF-κB, mTOR, autophagy, innate immunity, Magallana gigas, aquaculture</p>
</div>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">186972</post-id>	</item>
	</channel>
</rss>
